Complete Closure After EMR for Colon Polyps
(Closure-RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if closing the area after removing large flat colon polyps reduces complications compared to leaving it open. Participants will have their polyps removed, with some receiving prophylactic defect closure (a preventive measure to close the area) and others not. Researchers will monitor for side effects and observe if the polyps return over time. Individuals with large flat colon polyps scheduled for removal may be suitable candidates for this study. As an unphased trial, this study offers participants the chance to contribute to important research that could enhance future treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for patients undergoing EMR for large colorectal polyps?
Research shows that closing the area where a colon polyp is removed can make the procedure safer. Studies have found that using a closure method reduces the risk of issues like delayed bleeding or a tear in the colon wall. For instance, one study found that using clips to close the area after removing a polyp significantly reduced bleeding. Another report noted that closure methods were successful in about 90% of cases, further lowering the chance of bleeding.
If the area is not closed after polyp removal, there is a slightly higher risk of complications. However, severe bleeding remains rare, occurring in only a small percentage of cases. Overall, evidence suggests that closing the area is generally well-tolerated and can help prevent some problems after polyp removal.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the effectiveness of prophylactic defect closure after Endoscopic Mucosal Resection (EMR) for colon polyps. Unlike traditional EMR, which often leaves the resection site open, this approach uses a new generation closure device to potentially prevent complications like bleeding or perforation. This technique could enhance patient safety and recovery time, offering a significant improvement over the current standard of care, which typically involves monitoring and addressing complications after they occur.
What evidence suggests that prophylactic defect closure is effective for reducing adverse events after EMR for large colorectal polyps?
This trial will compare two approaches following Endoscopic Mucosal Resection (EMR) for colon polyps: prophylactic defect closure and no prophylactic defect closure. Research has shown that closing the opening left after polyp removal during EMR can lower the risk of bleeding. One study found that closing this opening successfully reduced the chance of delayed bleeding in about 90% of cases. However, another study found that closing the opening did not significantly reduce bleeding for certain types of polyps. Overall, evidence suggests that closing the opening may help reduce complications like bleeding after EMR for large polyps.23678
Are You a Good Fit for This Trial?
This trial is for individuals with large, flat colorectal polyps (≥20mm), also known as laterally spreading lesions. Participants should be scheduled for an endoscopic mucosal resection (EMR) and willing to follow up after the procedure. Specific inclusion and exclusion criteria details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Endoscopic Mucosal Resection (EMR) with or without prophylactic defect closure
Initial Follow-up
Participants are monitored for adverse events and emergency room visits between 14 and 44 days after EMR
6-month Follow-up
Participants undergo follow-up colonoscopy to assess for lesion recurrence
18-month Follow-up
Participants undergo follow-up colonoscopy to assess for lesion recurrence and histologic evaluation
What Are the Treatments Tested in This Trial?
Interventions
- No prophylactic defect closure
- Prophylactic defect closure
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor